UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

4 Dec 2023

UCB announces European Commission approval of ZILBRYSQ[®]▼ (zilucoplan) for the treatment of adults with generalized Myasthenia Gravis

Read More
1 Dec 2023

UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting

Read More
23 Nov 2023

Transparency notification Wellington

Read More
16 Nov 2023

‘Rheumacensus’ experts unite and call for essential psoriatic arthritis and axial spondyloarthritis care improvements

Read More
11 Nov 2023

Post hoc analysis showed meaningful efficacy of certolizumab pegol for RA patients with high Rheumatoid Factor (RF) levels

Read More
10 Nov 2023

UCB receives CHMP positive opinion for rozanolixizumab for treatment of adults with generalized myasthenia gravis in Europe

Read More

Stay up-to-date on the latest news and information from UCB